Analyst Ratings For Applied DNA Sciences Inc (NASDAQ:APDN)
Today, Maxim Group reiterated its Buy rating on Applied DNA Sciences Inc (NASDAQ:APDN) with a price target of $3.00.
There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Applied DNA Sciences Inc (NASDAQ:APDN) is Buy with a consensus target price of $3.00 per share, a potential 154.26% upside.
Some recent analyst ratings include
- 8/15/2018-Applied DNA Sciences Inc (NASDAQ:APDN) had its Buy rating reiterated by Maxim Group with a $3.00 price target
Recent Insider Trading Activity For Applied DNA Sciences Inc (NASDAQ:APDN)
Applied DNA Sciences Inc (NASDAQ:APDN) has insider ownership of 21.41% and institutional ownership of 9.46%.
- On 11/20/2014 James A Hayward, CEO, bought 76,923 with an average share price of $3.24 per share and the total transaction amounting to $249,230.52.
About Applied DNA Sciences Inc (NASDAQ:APDN)
Applied DNA Sciences, Inc. provides biotechnology based security solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, Asia, and internationally. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, a DNA marker to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high?value assets through inks, varnishes, and coatings; and SigNify IF portable DNA reader that provides real-time authentication of in the field?DNA. In addition, the company offers digitalDNA, a software platform to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Applied DNA Sciences, Inc. has a cooperative research and development agreement with the U.S. Army Research, Development and Engineering Command's Edgewood Chemical Biological Center; and a collaboration agreement with Colorcon, Inc. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Recent Trading Activity for Applied DNA Sciences Inc (NASDAQ:APDN)
Shares of Applied DNA Sciences Inc closed the previous trading session at 1,17 −0,33 22,00 % with 1.1 shares trading hands.